Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer
1997 ◽
Vol 33
(3)
◽
pp. 372-378
◽
Keyword(s):
1999 ◽
Vol 44
(0)
◽
pp. S13-S17
◽
2014 ◽
Vol 20
(4)
◽
pp. 501-506
◽
Keyword(s):
Keyword(s):
Keyword(s):
2003 ◽
Vol 9
(6)
◽
pp. 472-477
◽
Keyword(s):
2003 ◽
Vol 1
(5)
◽
pp. S118
Keyword(s):
1999 ◽
Vol 22
(2)
◽
pp. 162-167